More than 13 years of experience in Integrity & Compliance and Corporate Responsibility (CR) in academia and business.
Since 2005, working for Novartis with responsibilities for the development and management of a unique behavioral-based integrity program. In addition, responsibility for a variety of different CR initiatives, including linking societal issues with business activities, corporate innovation and leadership development.
Over the last years, focus on developing and implementing the Novartis CR strategy to create shared value for underserved patients and business. Speaker at leading universities (e.g. IMD, Cambridge, INSEAD, HSG), conferences and in-house senior management conferences (e.g. Fortune 500).
Awarded with the German Max Weber Price for Business Ethics in 2006.